Skip to main content
. Author manuscript; available in PMC: 2022 Mar 12.
Published in final edited form as: Clin Chem. 2011 Aug 22;57(10):1444–1451. doi: 10.1373/clinchem.2011.163139

Table 1.

Comparison of microplate and microfluidics assay protocols for Pompe and Fabry disorders.

Pompe assay (GAA) Fabry assay (GLA)
Microplate (Duke) Microfluidics (ALL) Microplate (Duke) Microfluidics (ALL)
EXT DI water 0.1% (wt/vol) Tween20 in water 1% sodium taurocholate in water 0.1% (wt/vol) Tween20 in water
Extraction time and conditions 360 μL EXT; incubated 1 h on ice 100 μL EXT; incubated 30 min at room temperature 250 μL EXT; incubated 1 h on ice 100 μL EXT; incubated 30 min at room temperature
Substrate stock 70 mmol/L in DMSO 70 mmol/L in DMSO 700 mmol/L in DMSO 700 mmol/L in DMSO
Inhibitor stock 80 μmol/L 8 mmol/L 0.5 mol/L in water 750 μmol/L in water
Final reagent during incubation 0.7 mmol/L 4-MU-α-gluc in sodium acetate, pH 3.8, with 8 μmol/L acarbose 2.5 mmol/L 4-MU-α-gluc in sodium acetate, pH 3.8, with 6 μmol/L acarbose 3.5 mmol/L 4-MU-α-gal in citrate-phosphate buffer, pH 4.5, with 75 mmol/L GalNac 5 mmol/L 4-MU-α-gal in 40 mmol/L sodium acetate, pH 4.5, with 75 μmol/L GalNac
Incubation conditions 20 h at 37 °C 6 h at 37 °C 20 h at 37 °C 6 h at 37 °C
STB 0.15 mol/L EDTA, pH 11.3 0.2 mol/L NaHCO3, pH 10.0, 0.01% (wt/vol) Tween20 0.15 mol/L EDTA, pH 11.3 0.2 mol/L NaHCO3, pH 10.0, 0.01% (wt/vol) Tween20